Jiangbo Pharmaceuticals (JGBO.OB) Announces Inclusion of Its Osteomyelitis Treatment Tablets in the Chinese National Insurance Directory
Jiangbo Pharmaceuticals, Inc., a researcher, developer, producer and marketer of pharmaceutical products in China, recently announced that the company’s Osteomyelitis…